Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
about
Angiopoietins 3 and 4: diverging gene counterparts in mice and humansMutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas")Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesisVE-PTP controls blood vessel development by balancing Tie-2 activityA gene for inherited cutaneous venous anomalies ("glomangiomas") localizes to chromosome 1p21-22.Biologic significance of angiopoietin-2 expression in human hepatocellular carcinomaThe orphan nuclear receptor COUP-TFII is required for angiogenesis and heart developmentIn silico cloning of novel endothelial-specific genesAngiopoietin-1 is essential in mouse vasculature during development and in response to injury.The Croonian Lecture 1997. The phosphorylation of proteins on tyrosine: its role in cell growth and diseaseLack of pericytes leads to endothelial hyperplasia and abnormal vascular morphogenesisThe role of pericytes in blood-vessel formation and maintenanceVascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularizationReceptor tyrosine kinase-mediated angiogenesisExtracranial vascular malformations (hemangiomas and vascular malformations) in children and adolescents - diagnosis, clinic, and therapyVascular anomalies: from genetics toward models for therapeutic trialsRapamycin improves TIE2-mutated venous malformation in murine model and human subjectsA Molecular Brake in the Kinase Hinge Region Regulates the Activity of Receptor Tyrosine KinasesFunctional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangiomaA lymphatic defect causes ocular hypertension and glaucoma in miceSomatic Activating PIK3CA Mutations Cause Venous MalformationUnsuspected role for the T-cell leukemia protein SCL/tal-1 in vascular developmentPolycystin 1 is required for the structural integrity of blood vesselsA murine model of hereditary hemorrhagic telangiectasiaIdentification of a novel marker for primordial smooth muscle and its differential expression pattern in contractile vs noncontractile cellsZebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity.Common and specific effects of TIE2 mutations causing venous malformationsGene profiling techniques and their application in angiogenesis and vascular development.Synchronous multiple small bowel intussusceptions in an adult with blue rubber bleb naevus syndrome: Report of a case and review of literature.Cerebral cavernous malformation: new molecular and clinical insights.The molecular basis of vascular disordersMicrovascular patterning is controlled by fine-tuning the Akt signal.Retinoic acid mediates regulation of network formation by COUP-TFII and VE-cadherin expression by TGFbeta receptor kinase in breast cancer cells.A noncoding antisense RNA in tie-1 locus regulates tie-1 function in vivo.KinMutBase, a database of human disease-causing protein kinase mutations.Vascular tumors and vascular malformations: are we at the dawn of a better knowledge?Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects.Disorganized vascular structures in sporadic venous malformations: a possible correlation with balancing effect between Tie2 and TGF-β.Mechanisms of vascular stability and the relationship to human disease
P2860
Q22008836-05FF301B-65F6-42BB-8F70-E096E6C661ABQ24292297-446FB5A5-500D-4CCF-BB4F-A0CB8B49C22FQ24302790-E19342D0-E6FA-4D0A-942B-B26280A8587DQ24311848-CD17BD6F-47A8-403A-9D5E-13718C837BC4Q24540299-F265156F-F3D2-4CFA-97FB-72A0D184475BQ24563486-CD4B1BE8-2AB7-4FC2-892C-F1FB5AAE586DQ24605541-856308E5-332B-433E-9C21-97539E81898CQ24622418-35088E00-7FCD-4D69-A1FB-75B4BC63CE41Q24629743-EEA956B7-B35A-4261-87EF-0B91B7D4A1DFQ24677033-BC8ECBAC-6A0B-4C8A-9E44-D3D50DCC6EC1Q24681191-EA0E3EF9-56EE-40A5-A7FF-C0764171C012Q24683881-1B940D9E-D3DB-4879-BB09-DB29C3FDDBE4Q26781833-75EC27F7-1CB0-44D2-BE76-4231D42F1D92Q27001612-7345B530-695D-409E-95A6-F7C336ADE03AQ27008530-AF6DE4B5-CFA9-4E44-93D3-D4B388DDCD4BQ27025402-3BEA95A7-7FC3-45A9-A045-5FFDC787DBE3Q27333126-06E19D26-CDDB-4C9F-B495-FBDE5FE925EDQ27647832-2F462AC1-F61D-49DB-9C50-65FE0AA4BD8CQ28137762-258E36CD-BC3D-4BBA-A4D4-7C1B575BC5CAQ28216461-578944C9-F6B6-4A29-BF17-76D9B10EAD65Q28247543-07BCA2D4-ADDA-4A21-BDF0-6D5FAD64407CQ28270654-8F0F2BBE-C8F7-45EF-862B-9EF24E3FBBFEQ28511667-31EB378D-0F4B-4E9B-9537-BA455965A36FQ28512594-FAE51D35-7EB1-47F6-B9F4-1815069DA434Q28592376-6706796B-B251-4E2E-82C9-CBA5D7F05948Q30442152-0733F5EF-A855-4364-8F78-A4743DBE4DF6Q30497797-05C9CFDD-9C97-4351-A89A-0BF0C9BA5252Q30670028-FD9168B2-3843-4ED5-8CA6-62BB0CD999AAQ30724640-7D2C3720-58E1-45F7-83A5-83A68953A7D1Q33315473-9DC972D3-BD37-4EBF-8A81-4DF46317CBC1Q33342264-AFD63D49-6B45-4C04-95F6-D5BFF614BE16Q33537697-35DDB740-FFCA-43F6-A465-912A29FA55F1Q33551411-0C79F6E9-3FB6-433D-A3B0-A42D57A8753FQ33553173-FEF8CE1C-68FA-4C7B-AD98-EBC2800C53B5Q33579502-07225DA5-A732-451B-B9EB-F7776932D0A0Q33610193-A2582EA4-4516-43BE-B6FF-C83A8F112B5EQ33670897-56FCB56A-35BE-4B9F-B222-843E7EBCD77DQ33739356-5654D84F-B577-495C-BB9F-EC06802D014DQ33807944-DF85553E-AD2C-4227-98B4-3558D5E75781Q33811222-4855008A-2490-48FF-9DFF-7AE78DE1FBE3
P2860
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2
description
1996 nî lūn-bûn
@nan
1996 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@ast
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@en
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@en-gb
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@nl
type
label
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@ast
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@en
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@en-gb
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@nl
prefLabel
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@ast
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@en
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@en-gb
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@nl
P2093
P3181
P1433
P1476
Vascular dysmorphogenesis caus ...... receptor tyrosine kinase TIE2
@en
P2093
A J Diamonti
B Goumnerov
D A Marchuk
J B Mulliken
J T Calvert
K L Carraway
L C Cantley
P304
P3181
P356
10.1016/S0092-8674(00)81814-0
P407
P577
1996-12-27T00:00:00Z